Skystar Bio-Pharmaceutical Company



Quote for Skystar Bio-Pharmaceutical Company

Last Trade:
-
Change:
--
Symbol:
SKBI
Status:
-
Listed In:
NASDAQ
P/E:
-
EPS:
-
Market cap:
-
Beta:
-
Open:
-
Prev Close:
-
Capital:
-
Volume:
-
Average vol:
-
Amount:
-
Day's Range:
-
52 week Range:
-
Update:-
Quote Delayed 15 Min.
Currency in USD Time=EDTSKBI quote

Summary for Skystar Bio-Pharmaceutical Company

Skystar Bio-Pharmaceutical Company (Skystar) is a holding company. Through its subsidiary, Xian Tianxing Bio-Pharmaceutical Co., Ltd. (Xian Tianxing), it researches, develops, manufactures and distributes veterinary health care and medical care products in the People's Republic of China (PRC). Skystar has four product lines: bio-pharmaceutical veterinary vaccine line, which includes over 10 products; veterinary medicine line for poultry and livestock, which includes over 220 products; feed additives line, which includes over 10 products, and micro-organism products line, which includes over 16 products. Its operations are carried out by Xian Tianxing, which it controls through contractual arrangements between Xian Tianxing and Sida Biotechnology (Xian) Co., Ltd. (Sida), the wholly owned subsidiary of Fortunate Time International Limited, the wholly-owned subsidiary of Skystar Bio-Pharmaceutical (Cayman) Holdings Co., Ltd. (Skystar Cayman), which became its wholly owned subsidiary.